• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PIM3 的存在增加了肝母细胞瘤的肿瘤发生和肿瘤起始细胞表型,并与患者生存率降低相关。

The presence of PIM3 increases hepatoblastoma tumorigenesis and tumor initiating cell phenotype and is associated with decreased patient survival.

机构信息

Department of Surgery, University of Alabama at Birmingham, Birmingham, AL.

Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL.

出版信息

J Pediatr Surg. 2019 Jun;54(6):1206-1213. doi: 10.1016/j.jpedsurg.2019.02.029. Epub 2019 Feb 28.

DOI:10.1016/j.jpedsurg.2019.02.029
PMID:30898394
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6545248/
Abstract

PURPOSE

Hepatoblastoma is the most common primary liver cancer of childhood and has few prognostic indicators. We have previously shown that Proviral Integration site for Moloney murine leukemia virus (PIM3) kinase decreased hepatoblastoma tumorigenicity. We sought to determine the effect of PIM3 overexpression on hepatoblastoma cells and whether expression of PIM3 correlated with patient/tumor characteristics or survival.

METHODS

The hepatoblastoma cell line, HuH6, and patient-derived xenograft, COA67, were utilized. Viability, proliferation, migration, sphere formation, and tumor growth in mice were assessed in PIM3-overexpressing cells. Immunohistochemistry was performed for PIM3 on patient samples. Correlation between stain score and clinical/pathologic characteristics was assessed.

RESULTS

PIM3 overexpression rescued the anti-proliferative effect observed with PIM3 knockdown. Sphere formation was increased in PIM3 overexpressing cells. Cells with PIM3 overexpression yielded larger tumors than those with empty vector. Seventy-four percent of samples expressed PIM3. There was no statistical difference in patient characteristics between subjects with strong versus weak PIM3 staining, but patients with strong PIM3 staining had decreased survival.

CONCLUSIONS

PIM3 expression plays a role in hepatoblastoma tumorigenesis. PIM3 was present in the majority of hepatoblastomas and higher PIM3 expression correlated with decreased survival. PIM3 warrants investigation as a therapeutic target and prognostic marker for hepatoblastoma.

摘要

目的

肝母细胞瘤是儿童最常见的原发性肝癌,其预后指标很少。我们之前已经表明,莫洛尼鼠白血病病毒(PIM3)激酶的前病毒整合位点(Proviral Integration site for Moloney murine leukemia virus (PIM3))降低了肝母细胞瘤的致瘤性。我们试图确定 PIM3 过表达对肝母细胞瘤细胞的影响,以及 PIM3 的表达是否与患者/肿瘤特征或生存相关。

方法

使用肝母细胞瘤细胞系 HuH6 和患者来源的异种移植 COA67。在过表达 PIM3 的细胞中评估细胞活力、增殖、迁移、球体形成和小鼠肿瘤生长。对患者样本进行 PIM3 免疫组织化学染色。评估染色评分与临床/病理特征之间的相关性。

结果

PIM3 过表达挽救了在 PIM3 敲低时观察到的抗增殖作用。过表达 PIM3 的细胞中球体形成增加。过表达 PIM3 的细胞产生的肿瘤比空载体的细胞大。74%的样本表达 PIM3。在具有强 versus 弱 PIM3 染色的患者之间,患者特征没有统计学差异,但具有强 PIM3 染色的患者生存时间缩短。

结论

PIM3 表达在肝母细胞瘤发生中起作用。PIM3 存在于大多数肝母细胞瘤中,较高的 PIM3 表达与生存时间缩短相关。PIM3 有望成为肝母细胞瘤的治疗靶点和预后标志物。

相似文献

1
The presence of PIM3 increases hepatoblastoma tumorigenesis and tumor initiating cell phenotype and is associated with decreased patient survival.PIM3 的存在增加了肝母细胞瘤的肿瘤发生和肿瘤起始细胞表型,并与患者生存率降低相关。
J Pediatr Surg. 2019 Jun;54(6):1206-1213. doi: 10.1016/j.jpedsurg.2019.02.029. Epub 2019 Feb 28.
2
CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells.CRISPR/Cas9 介导的 PIM3 基因敲除抑制人肝癌细胞的肿瘤发生和肿瘤干细胞特性。
Cancer Gene Ther. 2022 May;29(5):558-572. doi: 10.1038/s41417-021-00334-4. Epub 2021 Apr 16.
3
PIM3 kinase promotes tumor metastasis in hepatoblastoma by upregulating cell surface expression of chemokine receptor cxcr4.PIM3 激酶通过上调趋化因子受体 CXCR4 的细胞表面表达促进肝母细胞瘤的肿瘤转移。
Clin Exp Metastasis. 2022 Dec;39(6):899-912. doi: 10.1007/s10585-022-10186-3. Epub 2022 Oct 31.
4
LncRNA SNHG1 Accelerates Cell Proliferation, Migration, and Invasion of Hepatoblastoma Through Mediating miR-6838-5p/PIM3/RhoA Axis.长链非编码RNA SNHG1通过介导miR-6838-5p/PIM3/RhoA轴促进肝母细胞瘤细胞的增殖、迁移和侵袭。
Biochem Genet. 2024 Feb;62(1):59-76. doi: 10.1007/s10528-023-10404-x. Epub 2023 May 29.
5
PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma.PIM 激酶介导肝癌对顺铂化疗的耐药性。
Sci Rep. 2021 Mar 16;11(1):5984. doi: 10.1038/s41598-021-85289-0.
6
Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma.将PIM激酶作为人肝母细胞瘤的一种治疗策略
Oncotarget. 2018 Apr 27;9(32):22665-22679. doi: 10.18632/oncotarget.25205.
7
PIM447 inhibits oncogenesis and potentiates cisplatin effects in hepatoblastoma.PIM447 抑制肝癌的癌变并增强顺铂的疗效。
J Pediatr Surg. 2021 Jun;56(6):1157-1164. doi: 10.1016/j.jpedsurg.2021.02.039. Epub 2021 Feb 24.
8
Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas.肝母细胞瘤与相应正常肝脏之间的表达谱分析及差异筛选:鉴定PLK1癌基因的高表达作为肝母细胞瘤预后不良的指标
Oncogene. 2004 Aug 5;23(35):5901-11. doi: 10.1038/sj.onc.1207782.
9
Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma.靶向PIM激酶影响肝母细胞瘤中CD133肿瘤细胞群体的维持。
Transl Oncol. 2019 Feb;12(2):200-208. doi: 10.1016/j.tranon.2018.10.008. Epub 2018 Nov 6.
10
MicroRNA‑506 participates in pancreatic cancer pathogenesis by targeting PIM3.微小RNA-506通过靶向PIM3参与胰腺癌的发病机制。
Mol Med Rep. 2015 Oct;12(4):5121-6. doi: 10.3892/mmr.2015.4109. Epub 2015 Jul 22.

引用本文的文献

1
PIM3 Kinase: A Promising Novel Target in Solid Cancers.PIM3激酶:实体癌中一个有前景的新型靶点。
Cancers (Basel). 2024 Jan 26;16(3):535. doi: 10.3390/cancers16030535.
2
LncRNA SNHG1 Accelerates Cell Proliferation, Migration, and Invasion of Hepatoblastoma Through Mediating miR-6838-5p/PIM3/RhoA Axis.长链非编码RNA SNHG1通过介导miR-6838-5p/PIM3/RhoA轴促进肝母细胞瘤细胞的增殖、迁移和侵袭。
Biochem Genet. 2024 Feb;62(1):59-76. doi: 10.1007/s10528-023-10404-x. Epub 2023 May 29.
3
PIM3 kinase promotes tumor metastasis in hepatoblastoma by upregulating cell surface expression of chemokine receptor cxcr4.

本文引用的文献

1
Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma.将PIM激酶作为人肝母细胞瘤的一种治疗策略
Oncotarget. 2018 Apr 27;9(32):22665-22679. doi: 10.18632/oncotarget.25205.
2
A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma.基于新型细胞系的原位异种移植小鼠模型可重现人类肝母细胞瘤。
Sci Rep. 2017 Dec 19;7(1):17751. doi: 10.1038/s41598-017-17665-8.
3
Pim-3 Regulates Stemness of Pancreatic Cancer Cells via Activating STAT3 Signaling Pathway.Pim-3通过激活STAT3信号通路调控胰腺癌细胞的干性。
PIM3 激酶通过上调趋化因子受体 CXCR4 的细胞表面表达促进肝母细胞瘤的肿瘤转移。
Clin Exp Metastasis. 2022 Dec;39(6):899-912. doi: 10.1007/s10585-022-10186-3. Epub 2022 Oct 31.
4
The Role of PIM Kinases in Pediatric Solid Tumors.PIM激酶在儿童实体瘤中的作用。
Cancers (Basel). 2022 Jul 22;14(15):3565. doi: 10.3390/cancers14153565.
5
Targeting Host PIM Protein Kinases Reduces Mayaro Virus Replication.靶向宿主 PIM 蛋白激酶可降低马亚罗病毒的复制。
Viruses. 2022 Feb 18;14(2):422. doi: 10.3390/v14020422.
6
Identification of distinct tumor cell populations and key genetic mechanisms through single cell sequencing in hepatoblastoma.通过单细胞测序鉴定肝母细胞瘤中不同的肿瘤细胞群体和关键遗传机制。
Commun Biol. 2021 Sep 8;4(1):1049. doi: 10.1038/s42003-021-02562-8.
7
CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells.CRISPR/Cas9 介导的 PIM3 基因敲除抑制人肝癌细胞的肿瘤发生和肿瘤干细胞特性。
Cancer Gene Ther. 2022 May;29(5):558-572. doi: 10.1038/s41417-021-00334-4. Epub 2021 Apr 16.
8
PIM447 inhibits oncogenesis and potentiates cisplatin effects in hepatoblastoma.PIM447 抑制肝癌的癌变并增强顺铂的疗效。
J Pediatr Surg. 2021 Jun;56(6):1157-1164. doi: 10.1016/j.jpedsurg.2021.02.039. Epub 2021 Feb 24.
9
PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma.PIM 激酶介导肝癌对顺铂化疗的耐药性。
Sci Rep. 2021 Mar 16;11(1):5984. doi: 10.1038/s41598-021-85289-0.
10
ddRADseq-assisted construction of a high-density SNP genetic map and QTL fine mapping for growth-related traits in the spotted scat (Scatophagus argus).ddRADseq 辅助构建高密度 SNP 遗传图谱和生长相关性状的 QTL 精细定位在斑点叉尾鮰(Scatophagus argus)。
BMC Genomics. 2020 Apr 3;21(1):278. doi: 10.1186/s12864-020-6658-1.
J Cancer. 2017 Jun 2;8(9):1530-1541. doi: 10.7150/jca.18628. eCollection 2017.
4
Loss of EGFR-ASAP1 signaling in metastatic and unresectable hepatoblastoma.EGFR-ASAP1 信号通路失活与转移性和不可切除性肝母细胞瘤。
Sci Rep. 2016 Dec 2;6:38347. doi: 10.1038/srep38347.
5
Humanized Mouse Xenograft Models: Narrowing the Tumor-Microenvironment Gap.人源化小鼠异种移植模型:缩小肿瘤微环境差距
Cancer Res. 2016 Nov 1;76(21):6153-6158. doi: 10.1158/0008-5472.CAN-16-1260. Epub 2016 Sep 1.
6
Pure fetal histology subtype was associated with better prognosis of children with hepatoblastoma: A Chinese population-based study.纯胎儿组织学亚型与肝母细胞瘤患儿的更好预后相关:一项基于中国人群的研究。
J Gastroenterol Hepatol. 2016 Mar;31(3):621-7. doi: 10.1111/jgh.13165.
7
Pim Kinases Promote Migration and Metastatic Growth of Prostate Cancer Xenografts.Pim激酶促进前列腺癌异种移植瘤的迁移和转移生长。
PLoS One. 2015 Jun 15;10(6):e0130340. doi: 10.1371/journal.pone.0130340. eCollection 2015.
8
Functional role and therapeutic potential of the pim-1 kinase in colon carcinoma.pim-1 激酶在结肠癌中的功能作用和治疗潜力。
Neoplasia. 2013 Jul;15(7):783-94. doi: 10.1593/neo.13172.
9
Predictors of survival and incidence of hepatoblastoma in the paediatric population.儿童人群中肝母细胞瘤的生存和发病预测因素。
HPB (Oxford). 2013 Oct;15(10):741-6. doi: 10.1111/hpb.12112. Epub 2013 Apr 22.
10
The PIM family of serine/threonine kinases in cancer.癌症中的 PIM 家族丝氨酸/苏氨酸激酶。
Med Res Rev. 2014 Jan;34(1):136-59. doi: 10.1002/med.21284. Epub 2013 Apr 10.